Aspen Neuroscience

ASPE
12.3401.99% ( -0.250 )
Trading: Nov 16, 10:39:00 (EDT)

Profile

About

Aspen Neuroscience
Aspen Neuroscience
ASPE.US

Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative diseases. The company's develops ANPD001, an investigational single-dose, autologous dopaminergic neuronal precursor cell (DANPC) therapy for Parkinson's disease. It operates in the United States.

Profile

Company Name
Aspen Neuroscience, Inc.
Market
NasdaqGS
Founded
Industry
--
Fiscal Year End
--

Related Securities

Industry

Management